CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 2,317 shares (grant or award)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Option exercise EVP, General Counsel acquired 7,467 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 33,714 shares (to pay taxes)
- 4 Option exercise President, U.S. Businesses acquired 22,235 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 32,022 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 35,000,000 shares at $17.06 ($596,925,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes SVP, Controller and CAO gave up 747 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Results of operations · Other events
Page 19 of 121 · 2,419 filings